CONMED Corporation (CNMD) — Fair Value Analysis

Base-case fair value (P50): $50.93 · Current price: $35.49 · Verdict: Undervalued

The Verdict on CNMD

CONMED CORP (CNMD) currently trades at $35.49, yet our Monte Carlo simulations identify a median fair value (P50) of $50.93. This implies a significant +43.5% potential against its current market price. Our analysis concludes that CNMD is "Fairly Valued," suggesting that while it’s not steeply discounted, there’s a clear path for price appreciation toward its intrinsic value. This assessment is underpinned by a rigorous evaluation of various forward-looking scenarios.

How CNMD stacks up against peers

CNMD's operational and financial health is categorized as "average" relative to its sector. This average quality tier suggests that while the company maintains a solid foundation, it doesn't possess the standout financial characteristics that would warrant a premium valuation far exceeding its median fair value of $50.93. The implied +43.5% indicates that current market sentiment may not fully reflect CNMD's fundamental strength, even with its average quality standing, leaving room for a re-rating as investors converge on its intrinsic value.

What this means for investors

Based on our Monte Carlo simulations, CNMD is not overvalued at its current price of $35.49. The substantial +43.5% toward the median fair value of $50.93 points to a compelling opportunity for investors seeking exposure to a "Fairly Valued" company with an average quality tier. Understanding these simulated scenarios is crucial for making informed investment decisions. Sign up for FairCurve today to see the full bear/bull distribution for CNMD and track its fair value as new fundamentals are released.